Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CRISPR Therapeutics Q2 EPS $9.44 Up From $(1.30) YoY

CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly earnings of $9.44 per share. This is a 826.15 percent increase over losses of $(1.30) per share from the same period last year.

byBenzinga Newsdesk

July 29, 2021

1 minute read

CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly earnings of $9.44 per share. This is a 826.15 percent increase over losses of $(1.30) per share from the same period last year.

Raymond James Maintains Outperform on Paylocity Holding, Raises Price Target to $355

By Benzinga Newsdesk

November 5, 10:42 AM

Raymond James analyst Brian Peterson maintains Paylocity Holding (NASDAQ:PCTY) with a Outperform and raises the price target from $270 to $355.

PCTY

Earnings

Recap: F45 Training Holdings Q2 Earnings

By Benzinga Insights

August 15, 5:31 PM

F45 Training Holdings (NYSE:FXLV) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings F45 Training Holdings posted an EPS of $-0.36.

FXLV